Protagonist Announces Nomination of PN-881, a Potential Best-in-Class Oral Peptide IL-17 Antagonist Development Candidate

November 21, 2024 Conference Call and Webcast Details The dial-in numbers for Protagonist’s investor update on Thursday, November 21st at 4:30 pm ET are: US-based Investors : 1-877-407-0752 International Investors : 1-201-389-0912 Conference Call ID : 13750274 Webcast Link >